Internal Medicine · Florissant, MO
NPI
1811963903
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
91 Florissant Oaks Shop Ctr
Florissant, MO, 63031
Phone (314) 831-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,277 services
Medicare patients, 2024
310
Average age 73
Drug cost, 2024
$2.0M
20,144 prescriptions
Company payments, 2025
$1,362
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew M Kazdan was code 99214 (office e&m - established), 598 times for 307 patients. In total Andrew M Kazdan billed 1,277 services in 31 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 598 | 307 | $75.22 | $45K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 164 | 164 | $124.53 | $20K |
| G0008 Administration of influenza virus vaccine | Office | 87 | 86 | $31.21 | $2,715 |
| 90662 Vaccine Product | Office | 76 | 75 | $81.30 | $6,179 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 68 | $12.60 | $857 |
| G0009 Administration of pneumococcal vaccine | Office | 51 | 51 | $31.21 | $1,592 |
| 90677 Vaccine Product | Office | 45 | 45 | $289.22 | $13K |
| 99213 Office E&M - Established | Office | 38 | 35 | $61.12 | $2,323 |
| 96372 Injection Administration | Office | 38 | 11 | $9.01 | $342 |
| 36415 Venipuncture Blood Collection | Office | 17 | 13 | $8.65 | $147 |
By year: 2022 $125K for 1,568 services; 2023 $101K for 1,270 services; 2024 $99K for 1,277 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 13 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew M Kazdan prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,121 prescriptions and refills. In total Andrew M Kazdan wrote 20,144 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,121 | 3,177 | 290 | $11K |
| Metoprolol Succinate Generic | 682 | 1,926 | 199 | $8,234 |
| Ezetimibe Generic | 622 | 1,853 | 190 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 617 | 617 | 130 | $16K |
| Pravastatin Sodium Generic | 616 | 1,850 | 187 | $5,968 |
| Amlodipine Besylate Generic | 597 | 1,692 | 176 | $3,008 |
| Atorvastatin Calcium Generic | 561 | 1,579 | 177 | $4,596 |
| Gabapentin Generic | 465 | 1,070 | 154 | $8,657 |
| Montelukast Sodium Generic | 435 | 1,146 | 129 | $4,846 |
| Alprazolam Generic | 425 | 465 | 98 | $1,625 |
| Rosuvastatin Calcium Generic | 423 | 1,219 | 131 | $5,675 |
| Omeprazole Generic | 410 | 1,080 | 118 | $6,201 |
| Losartan Potassium Generic | 361 | 994 | 109 | $2,567 |
| Lisinopril Generic | 357 | 1,065 | 103 | $2,247 |
| Metformin Hcl Generic | 343 | 992 | 105 | $2,025 |
Brand drugs: 2,662 claims; generic drugs: 17,363 claims; opioid claims: 1,438.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew M Kazdan $1,362 ($1,362 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $206.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $206 |
| Amgen Inc. AMGN | 9 | $171 |
| Novo Nordisk Inc NVO | 12 | $168 |
| GlaxoSmithKline, LLC. GSK | 16 | $162 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $112 |
| Lilly USA, LLC LLY | 5 | $97.8 |
| Pfizer Inc. PFE | 4 | $61.98 |
| Abbott Laboratories ABT | 3 | $60.72 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $48.29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $37.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.